Moreover, we confirmed that CC1007 exhibited an overt growth-inhibiting effect on primary CD34+ BCR-ABL1− pre-B-ALL cells, corresponding to BCR-ABL1− pre-B-ALL mononuclear cells (MNCs) (Fig. 1c and Table 1). This evidence concerns the gene CD34 and acute lymphoblastic leukemia.